Evaluation of efficacy and safety of opipramol versus alprazolam in the treatment of generalized anxiety disorder: a randomized, open label, active controlled, multicentric study.
Phase of Trial: Phase III
Latest Information Update: 02 Sep 2016
At a glance
- Drugs Alprazolam (Primary) ; Opipramol (Primary)
- Indications Generalised anxiety disorder
- Focus Therapeutic Use
- Sponsors Sun Pharmaceutical Industries
- 09 Apr 2010 Status changed from not yet recruiting to recruiting as reported by Clinical Trials Registry - India record.
- 04 Apr 2010 New trial record